Yahoo! Finance Search - Finance Home - Yahoo! - Help

Saturday, July 4 2009 1:28am ET - U.S. Markets Closed.
Industry Center - Drug Manufacturers - Major
Industry Center > Drug Manufacturers - Major > News
More On This Industry
· Summary
News
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Diagnostic Substances
· Drug Delivery
· Drug Manufacturers - Other
· Drug Related Products
· Drugs - Generic
· REIT - Retail
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Biotechnology
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Conglomerates
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
 
Drug Manufacturers - Major News
View: Latest News | Top Stories
Friday, Jul 3, 2009
·A Rocky Week For Abbott Labs
at Investopedia - Fri 1:30 pm ET
·Johnson & Johnson Completes Initial Tender Offer for Cougar Biotechnology
PR Newswire - Fri 8:53 am ET
·[external] European media stocks make gains
at FT.com - Fri 6:20 am ET
·Big Win for J&J with Elan Deal
at Seeking Alpha - Fri 5:43 am ET
·J&J comes riding to Elan's rescue
at Seeking Alpha - Fri 5:35 am ET
Thursday, Jul 2, 2009
·[$$] U.K. Issues Recall Of Various Generics
at The Wall Street Journal Online - Thu 11:09 pm ET
·[$$] J&J Pays $1.5 Billion for Elan Stake, Takes Aim at Alzheimer's
at The Wall Street Journal Online - Thu 11:09 pm ET
·[external] Temps suffer as US job cuts spread
at FT.com - Thu 6:55 pm ET
·[external] J&J takes $1bn Elan stake
at FT.com - Thu 6:45 pm ET
·Sanofi-Aventis arrhythmia drug Multaq approved
AP - Thu 6:27 pm ET
·Likely FDA Approval Gives Dendreon A Lift
Investor's Business Daily - Thu 6:14 pm ET
·Johnson & Johnson pays $1B for Elan stake
AP - Thu 6:04 pm ET
·GlaxoSmithKline buys products from Bristol-Myers
AP - Thu 6:00 pm ET
·J&J buys $1 billion Elan stake, gains Alzheimer's R&D
Reuters - Thu 4:40 pm ET
·[external] At Last, a Heartening Drug Approval
at Motley Fool - Thu 4:20 pm ET
·[external] Squeezing Blood From a Half-Dollar
at Motley Fool - Thu 3:29 pm ET
·Elan Shares Spike on JNJ Investment News
at Seeking Alpha - Thu 3:26 pm ET
·[external] Top Takes From RealMoney
at TheStreet.com - Thu 2:37 pm ET
·[external] Biotech Stocks: Drug stocks slide; Elan climbs on J&J deal
at MarketWatch - Thu 1:41 pm ET
·Energizer Shaving P&G's Share
Zacks.com - Thu 1:24 pm ET
More Latest News...
Sponsor Results
General Appliance Repair
Read reviews for this business with directions, offers and more.
Losangeles.Citysearch.com
Pharma Partnership
Pharmaceutical development partner. Learn why companies choose TEVA.
www.TevaPartners.com
Who Wants a Pharmaceutical Sales Career?
A Proven System to Get You a Career In Pharmaceutical Sales.
www.PharmaCareerGuide.com
(What's This?)
  

RSS Feeds

Add headlines to your
personalized My Yahoo! Page
( About My Yahoo! and RSS )

Drug Manufacturers - Major Headlines
More Finance RSS Feeds

Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2009 Morningstar, Inc. All Rights Reserved. Company information © 2009 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo! Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2009, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo! nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo! site, a user agrees not to redistribute the information found therein.
Questions or Comments?